Header Logo

Connection

Maria Papathanasopoulos to HIV-1

Back to Details
This is a "connection" page, showing publications Maria Papathanasopoulos has written about HIV-1.
Maria Papathanasopoulos
Connection Strength
4,704
HIV-1
  1. Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics. Biochem Biophys Res Commun. 2022 07 05; 612:181-187.
    View in: PubMed
    Score: 0,443
  2. Env-2dCD4 S60C complexes act as super immunogens and elicit potent, broadly neutralizing antibodies against clinically relevant human immunodeficiency virus type 1 (HIV-1). Vaccine. 2015 Nov 17; 33(46):6298-306.
    View in: PubMed
    Score: 0,281
  3. Generation and characterization of an HIV-1 subtype C transmitted and early founder virus consensus sequence. AIDS Res Hum Retroviruses. 2014 Oct; 30(10):1001-5.
    View in: PubMed
    Score: 0,259
  4. Viral tropism and antiretroviral drug resistance in HIV-1 subtype C-infected patients failing highly active antiretroviral therapy in Johannesburg, South Africa. AIDS Res Hum Retroviruses. 2014 Mar; 30(3):289-93.
    View in: PubMed
    Score: 0,248
  5. Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patient. Virus Genes. 2010 Dec; 41(3):358-60.
    View in: PubMed
    Score: 0,201
  6. Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study. AIDS Res Hum Retroviruses. 2010 Jun; 26(6):705-9.
    View in: PubMed
    Score: 0,194
  7. Natural polymorphisms of integrase among HIV type 1-infected South African patients. AIDS Res Hum Retroviruses. 2010 Apr; 26(4):489-93.
    View in: PubMed
    Score: 0,192
  8. Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children. AIDS Res Hum Retroviruses. 2009 Nov; 25(11):1141-8.
    View in: PubMed
    Score: 0,186
  9. Genotypic characterization and comparison of full-length envelope glycoproteins from South African HIV type 1 subtype C primary isolates that utilize CCR5 and/or CXCR4. AIDS Res Hum Retroviruses. 2008 May; 24(5):743-51.
    View in: PubMed
    Score: 0,168
  10. Emergence of X4 usage among HIV-1 subtype C: evidence for an evolving epidemic in South Africa. AIDS. 2008 Apr 23; 22(7):896-9.
    View in: PubMed
    Score: 0,168
  11. Molecular characterization of the HIV type 1 subtype C accessory genes vif, vpr, and vpu. AIDS Res Hum Retroviruses. 2007 Feb; 23(2):322-30.
    View in: PubMed
    Score: 0,154
  12. Purification and partial characterization of R5, R5X4, and X4 HIV-1 subtype C envelope glycoproteins expressed in insect cells. J Med Virol. 2005 Aug; 76(4):459-63.
    View in: PubMed
    Score: 0,139
  13. Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir. Viruses. 2024 12 06; 16(12).
    View in: PubMed
    Score: 0,133
  14. K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine. Viruses. 2024 Sep 20; 16(9).
    View in: PubMed
    Score: 0,131
  15. Full-length genome characterization of HIV type 1 subtype C isolates from two slow-progressing perinatally infected siblings in South Africa. AIDS Res Hum Retroviruses. 2003 Nov; 19(11):1033-7.
    View in: PubMed
    Score: 0,123
  16. Evolution and diversity of HIV-1 in Africa--a review. Virus Genes. 2003; 26(2):151-63.
    View in: PubMed
    Score: 0,116
  17. HIV-1 bispecific antibody iMab-N6 exhibits enhanced breadth but not potency over its parental antibodies iMab and N6. Virol J. 2022 09 07; 19(1):143.
    View in: PubMed
    Score: 0,114
  18. Full-length genome analysis of HIV-1 subtype C utilizing CXCR4 and intersubtype recombinants isolated in South Africa. AIDS Res Hum Retroviruses. 2002 Aug 10; 18(12):879-86.
    View in: PubMed
    Score: 0,113
  19. Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection. Sci Rep. 2020 09 28; 10(1):15866.
    View in: PubMed
    Score: 0,099
  20. Engineering and characterising a novel, highly potent bispecific antibody iMab-CAP256 that targets HIV-1. Retrovirology. 2019 11 08; 16(1):31.
    View in: PubMed
    Score: 0,093
  21. Redox exchange of the disulfides of human two-domain CD4 regulates the conformational dynamics of each domain, providing insight into its mechanisms of control. Biochem Biophys Res Commun. 2018 03 04; 497(2):811-817.
    View in: PubMed
    Score: 0,083
  22. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey. PLoS One. 2016; 11(12):e0166305.
    View in: PubMed
    Score: 0,076
  23. Prevalence of Antiretroviral Drug Resistance in Patients Who Are Not Responding to Protease Inhibitor-Based Treatment: Results From the First National Survey in South Africa. J Infect Dis. 2016 Dec 15; 214(12):1826-1830.
    View in: PubMed
    Score: 0,076
  24. HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. J Antimicrob Chemother. 2017 01; 72(1):210-219.
    View in: PubMed
    Score: 0,075
  25. Thioredoxin (Trx1) regulates CD4 membrane domain localization and is required for efficient CD4-dependent HIV-1 entry. Biochim Biophys Acta. 2016 09; 1860(9):1854-63.
    View in: PubMed
    Score: 0,073
  26. Functional roles of HIV-1 Vpu and CD74: Details and implications of the Vpu-CD74 interaction. Cell Immunol. 2015 Nov-Dec; 298(1-2):25-32.
    View in: PubMed
    Score: 0,070
  27. High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa. PLoS One. 2015; 10(2):e0118145.
    View in: PubMed
    Score: 0,067
  28. High-level cross-resistance to didanosine observed in South African children failing an abacavir- or stavudine-based 1st-line regimen. PLoS One. 2014; 9(5):e97067.
    View in: PubMed
    Score: 0,064
  29. Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization. J Biol Chem. 2014 Apr 11; 289(15):10455-10465.
    View in: PubMed
    Score: 0,063
  30. HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone. PLoS One. 2012; 7(4):e34708.
    View in: PubMed
    Score: 0,055
  31. Modification of HIV-1 reverse transcriptase and integrase activity by gold(III) complexes in direct biochemical assays. Bioorg Med Chem. 2012 Jan 01; 20(1):401-7.
    View in: PubMed
    Score: 0,054
  32. Natural killer cells that respond to human immunodeficiency virus type 1 (HIV-1) peptides are associated with control of HIV-1 infection. J Infect Dis. 2010 Nov 01; 202(9):1444-53.
    View in: PubMed
    Score: 0,050
  33. Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1. J Virol Methods. 2010 Feb; 163(2):505-8.
    View in: PubMed
    Score: 0,047
  34. Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1. J Immunol. 2009 May 15; 182(10):5914-8.
    View in: PubMed
    Score: 0,045
  35. Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa. AIDS Res Hum Retroviruses. 2007 Feb; 23(2):316-21.
    View in: PubMed
    Score: 0,039
  36. Phenotypic characterization of HIV type 1 isolates from Ghana. AIDS Res Hum Retroviruses. 2007 Jan; 23(1):144-52.
    View in: PubMed
    Score: 0,038
  37. Use of alternate coreceptors on primary cells by two HIV-1 isolates. Virology. 2005 Aug 15; 339(1):136-44.
    View in: PubMed
    Score: 0,035
  38. Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence. AIDS Res Hum Retroviruses. 2005 Jan; 21(1):103-9.
    View in: PubMed
    Score: 0,033
  39. Sensitivity of HIV type 1 subtype C isolates to the entry inhibitor T-20. AIDS Res Hum Retroviruses. 2004 May; 20(5):477-82.
    View in: PubMed
    Score: 0,032
  40. Detection of human immunodeficiency virus type 1 envelope peptide- stimulated T-helper cell responses and variations in the corresponding regions of viral isolates among vertically infected children. Virus Genes. 2004 Apr; 28(3):311-8.
    View in: PubMed
    Score: 0,032
  41. Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates. Virus Genes. 2003 Jan; 26(1):49-56.
    View in: PubMed
    Score: 0,029
  42. The evaluation of statins as potential inhibitors of the LEDGF/p75-HIV-1 integrase interaction. Chem Biol Drug Des. 2015 Mar; 85(3):290-5.
    View in: PubMed
    Score: 0,016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.